LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

Search

Fulgent Genetics Inc

Closed

SectorHealthcare

20.73 -2.36

Overview

Share price change

24h

Current

Min

20.66

Max

21.31

Key metrics

By Trading Economics

Income

-5.7M

-12M

Sales

-2.8M

73M

EPS

0.04

Profit margin

-16.197

Employees

1,313

EBITDA

-2M

-12M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+12.73% upside

Dividends

By Dow Jones

Next Earnings

1 sie 2025

Market Stats

By TradingEconomics

Market Cap

57M

629M

Previous open

23.09

Previous close

20.73

News Sentiment

By Acuity

50%

50%

174 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Fulgent Genetics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 cze 2025, 17:05 UTC

Acquisitions, Mergers, Takeovers

UniCredit's $10 Billion-Plus Bid for Banco BPM Gets EU Clearance

4 cze 2025, 23:45 UTC

Market Talk

Nikkei May Fall on Signs of Weakness in U.S. Economy -- Market Talk

4 cze 2025, 23:45 UTC

Market Talk

Gold Steady, Underpinned by Weak U.S. Economic Data -- Market Talk

4 cze 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Gran Tierra Energy: To Sell Wholly Owned Subsidiary Gran Tierra North Sea Limited to NEO Energy for $7.5M >GTE.T

4 cze 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Gran Tierra Energy: Transaction Is Expected to Close in 3Q >GTE.T

4 cze 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Gran Tierra Energy: NEO Energy Is a Private Upstream Co and Independent Operator in the United Kingdom Continental Shelf >GTE.T

4 cze 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

New MicroStrategy Preferred, a Bitcoin Play, Should Yield 10% or More -- Barrons.com

4 cze 2025, 20:44 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications: Approvals Received From Canadian Football League, Major League Soccer

4 cze 2025, 20:44 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications: Approval Received From American Hockey League

4 cze 2025, 20:43 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications: Approvals Received From National Hockey League, National Basketball Association

4 cze 2025, 20:42 UTC

Acquisitions, Mergers, Takeovers

Rogers Communications Gets League Approvals to Buy Bell's 37.5% Stake in Maple Leaf Sports & Entertainment >RCI.A.T

4 cze 2025, 20:37 UTC

Earnings

These Stocks Moved the Most Today: Broadcom, Tesla, Dollar Tree, ON Semi, CrowdStrike, Guidewire, Asana, and More -- Barrons.com

4 cze 2025, 20:34 UTC

Market Talk

Starbucks Names COO -- Market Talk

4 cze 2025, 20:23 UTC

Acquisitions, Mergers, Takeovers

Transocean Move Will Contribute Approximately $100 M in Backlog, Excluding Additional Services >RIG

4 cze 2025, 20:23 UTC

Acquisitions, Mergers, Takeovers

Transocean Program Expected to Commence in the 1Q in Direct Continuation of the Rig's Current Program >RIG

4 cze 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

Transocean Two-well Option Was Exercised for the Transocean Spitsbergen in Norway >RIG

4 cze 2025, 19:06 UTC

Market Talk

Oil Futures Settle Lower in Choppy Trade -- Market Talk

4 cze 2025, 19:04 UTC

Market Talk

U.S. Natural Gas Ends Flat Ahead of Storage Data -- Market Talk

4 cze 2025, 18:48 UTC

Market Talk

Gold Turns Higher on Increased Uncertainty -- Market Talk

4 cze 2025, 18:42 UTC

Earnings

These Stocks Are Moving the Most Today: Broadcom, Tesla, Dollar Tree, ON Semi, CrowdStrike, Guidewire, Asana, and More -- Barrons.com

4 cze 2025, 17:48 UTC

Market Talk

Oil Futures Down Despite Big U.S. Crude Stock Draw -- Market Talk

4 cze 2025, 17:41 UTC

Market Talk

Bank of Canada Made 'Foolhardy' Attempt to Play Down Economic Weakness -- Market Talk

4 cze 2025, 16:50 UTC

Market Talk

CVS Seen as Biggest Beneficiary of Rite Aid Closures -- Market Talk

4 cze 2025, 16:48 UTC

Market Talk

End of U.S. Exceptionalism Bodes Well for Carry Trade -- Market Talk

4 cze 2025, 16:37 UTC

Acquisitions, Mergers, Takeovers

UniCredit: Transaction Will Be Authorized

4 cze 2025, 16:37 UTC

Acquisitions, Mergers, Takeovers

UniCredit: European Commission Won't Initiate In-Depth Investigation

4 cze 2025, 16:35 UTC

Acquisitions, Mergers, Takeovers

UniCredit Received EU Letter on Closure of Preliminary Review of Banco BPM Deal

4 cze 2025, 16:32 UTC

Market Talk

BOC's Macklem Highlights Economy's 'Resilience' to Tariffs -- Market Talk

4 cze 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 cze 2025, 15:57 UTC

Market Talk

Gold Futures Rise on Persistent Market Nerves -- Market Talk

Peer Comparison

Price change

Fulgent Genetics Inc Forecast

Price Target

By TipRanks

12.73% upside

12 Months Forecast

Average 24 USD  12.73%

High 25 USD

Low 23 USD

Based on 2 Wall Street analysts offering 12 month price targets forFulgent Genetics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

17.32 / 19.04Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Neutral Evidence

Sentiment

By Acuity

174 / 380 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.